GlassScriptPhysician profile
Caleb Alan Whitenack
NPI 1770872160
$68,047.91
in general payments reported to CMS, 2019-2025
29 companies · $8,418 in 2025
The $8,418 reported for 2025 was more than what 95% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,918 · 2020: $2,937 · 2021: $4,208 · 2022: $1,331 · 2023: $32K · 2024: $17K · 2025: $8,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $43K · Honoraria: $7,225 · Food and Beverage: $3,638 · Travel and Lodging: $3,507 · Education: $83.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $43,200.00 |
| Honoraria | $7,225.00 |
| Food and Beverage | $3,638.45 |
| Travel and Lodging | $3,506.71 |
| Education | $83.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $55,232.17 | 2023-2025 | Auvelity, Sunosi |
| Allergan, INC. | $3,759.38 | 2019-2021 | |
| Abbvie INC. | $2,745.67 | 2021-2023 | Vraylar |
| Neuronetics, INC. | $1,600.72 | 2019-2023 | Neurostar Tms Therapy System |
| Sunovion Pharmaceuticals INC. | $586.71 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $537.39 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $427.99 | 2019-2023 | Austedo, Austedo Xr |
| Lundbeck LLC | $390.40 | 2019-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $311.75 | 2019-2023 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $291.83 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $283.96 | 2019-2023 | Trintellix |
| Bausch Health US, LLC | $269.16 | 2019-2023 | Aplenzin |
| Neurocrine Biosciences, INC. | $200.38 | 2019-2023 | Ingrezza |
| Supernus Pharmaceuticals, INC. | $183.97 | 2021-2022 | |
| Alkermes, INC. | $178.79 | 2019-2023 | Aristada, Lybalvi |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $167.97 | 2019-2023 | Jornay Pm |
| Neos Therapeutics, LP | $133.03 | 2019-2022 | |
| Eisai INC. | $120.88 | 2020-2021 | |
| Adlon Therapeutics L.P. | $102.48 | 2019-2021 | |
| Tris Pharma INC | $100.79 | 2019-2023 | Dyanavel Xr |
| Avanir Pharmaceuticals, INC. | $98.59 | 2019-2020 | |
| Livanova USA, INC. | $78.83 | 2023 | Vns Therapy Symmetry Model 8103 Generator |
| Merck Sharp & Dohme LLC | $70.74 | 2020-2023 | Belsomra |
| Vanda Pharmaceuticals INC. | $55.87 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $36.68 | 2022-2023 | Quviviq |
| Shire North American Group INC | $30.55 | 2019 | |
| Corium, LLC | $18.98 | 2022 | |
| Alfasigma USA, INC. | $18.75 | 2020 | |
| Avion Pharmaceuticals | $13.50 | 2023 | Methylphenidate Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caleb Whitenack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.